Recommended composition of influenza virus vaccines for use in the 2013 southern hemisphere influenza season.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Releve epidemiologique hebdomadaire

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Environmental Science

• Identifiers
  PMID 23074737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains.

  2026cites this paper
• Genetic characteristics and epidemiology of influenza and respiratory syncytial viruses associated with acute respiratory infections in Thailand

  2025cites this paper
• Population-Based Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza Infection in Southern China, 2023–2024 Season

  2024cites this paper
• Immunogenicity and Safety of a Quadrivalent Influenza Vaccine in Population Aged 3 Years and Older in Chile and the Philippines: A Phase 3, Non-Inferiority, Double-Blind, Randomized Controlled Clinical Trial

  2024cites this paper
• Comprehensive molecular epidemiology of influenza viruses in Brazil: insights from a nationwide analysis

  2024cites this paper
• Cost‐effectiveness analysis of cell‐based versus egg‐based quadrivalent influenza vaccines in the pediatric population in Taiwan

  2024cites this paper
• The resurgence of influenza A/H3N2 virus in Australia after the relaxation of COVID‐19 restrictions during the 2022 season

  2024cites this paper
• Comparative Analysis of Influenza Viruses Isolated from Early and Severe Cases in Epidemic Seasons before and during the COVID-19 Pandemic in Russia (2019–2023)

  2023cites this paper
• Development of PREDAC-H1pdm to model the antigenic evolution of influenza A/(H1N1) pdm09 viruses

  2023cites this paper
• Attitudes Regarding Influenza Vaccination Among Public Health Workers during COVID-19 Pandemic — China, September 2022

  2023cites this paper
• Influenza hospitalisations in Spain between the last influenza and COVID-19 pandemic (2009–2019)

  2023cites this paper
• Increased Mortality Risks from a Spectrum of Causes of Tropical Cyclone Exposure — China, 2013–2018

  2023cites this paper
• Clinical, epidemiological, and genomic characteristics of a seasonal influenza A virus outbreak in Beijing: A descriptive study

  2023cites this paper
• Suspected Legionella Transmission from a Single Donor to Two Lung Transplant Recipients — Pennsylvania, May 2022

  2023cites this paper
• Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalizations — REVELAC–i Network, March–July 2023

  2023cites this paper
• Communicable Diseases Intelligence

  2023cites this paper
• Regional characteristics of influenza seasonality patterns in mainland China, 2005-2017: a statistical modeling study.

  2022cites this paper
• Re-Emergence of Circulation of Seasonal Influenza during COVID-19 Pandemic in Russia and Receptor Specificity of New and Dominant Clade 3C.2a1b.2a.2 A(H3N2) Viruses in 2021–2022

  2022cites this paper
• Cost-Effectiveness Analysis of Cell Versus Egg-Based Seasonal Influenza Vaccination in Children and Adults in Argentina

  2022cites this paper
• Comparative Effectiveness of Influenza Vaccines Among US Medicare Beneficiaries Ages 65 Years and Older During the 2019–2020 Season

  2021cites this paper
• Could trivalent LAIV protect against both genetic lineages of influenza B virus?

  2019cites this paper
• Estimation of the Effectiveness of Quadrivalent Influenza Vaccines by Distinguishing Between Influenza A (H1N1) pdm09 and Influenza A (H3N2) Using Rapid Influenza Diagnostic Tests During the 2018-2019 Season

  2019cites this paper
• Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations – Latin America, 2013 q the REVELAC-i network participants

  2018cites this paper
• Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model

  2018cites this paper
• Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations – Latin America, 2013

  2017cites this paper
• Predicting clinical severity based on substitutions near epitope A of influenza A/H3N2.

  2015cites this paper
• Influenza evolution and H3N2 vaccine effectiveness, with application to the 2014/2015 season

  2015cites this paper
• Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia.

  2015cites this paper
• 4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany

  2014cites this paper
• Computational Prediction of Vaccine Strains for Human Influenza A (H3N2) Viruses

  2014cites this paper
• Influenza B outbreak on a cruise ship off the São Paulo Coast, Brazil.

  2014cites this paper
• WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013.

  2014cites this paper
• Implementation of Influenza-like illness Sentinel Surveillance in Togo

  2014cites this paper
• Structural Stability of Influenza A(H1N1)pdm09 Virus Hemagglutinins

  2014cites this paper
• Antigenically intact hemagglutinin in circulating avian and swine influenza viruses and potential for H3N2 pandemic

  2013cites this paper
• Antigenic Drift of the Pandemic 2009 A(H1N1) Influenza Virus in a Ferret Model

  2013cites this paper
• The use of pyrosequencer-generated sequence-signatures to identify the influenza B-lineage and the subclade of the B/Yamataga-lineage viruses from currently circulating human influenza B viruses.

  2013cites this paper
• Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children

  2013cites this paper
• Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years

  2013cites this paper
• Survey of causative agents for acute respiratory infections among patients in Khartoum- State, Sudan, 2010–2011

  2013cites this paper
• Influenza in the tropics

  2010cites this paper